These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 7398602)

  • 1. Correlation between daily fluctuations of carbamazepine serum levels and intermittent side effects.
    Höppener RJ; Kuyer A; Meijer JW; Hulsman J
    Epilepsia; 1980 Aug; 21(4):341-50. PubMed ID: 7398602
    [No Abstract]   [Full Text] [Related]  

  • 2. Interdosage fluctuations in plasma carbamazepine concentration determine intermittent side effects.
    Tomson T
    Arch Neurol; 1984 Aug; 41(8):830-4. PubMed ID: 6466158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intermittent complete atrioventricular block after long term low-dose carbamazepine therapy with a serum concentration less than the therapeutic level.
    Ide A; Kamijo Y
    Intern Med; 2007; 46(9):627-9. PubMed ID: 17473503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Decrease of folic acid and cognitive alterations in patients with epilepsy treated with phenytoin or carbamazepine, pilot study].
    Hernández R; Fernández Mde L; Miranda G; Suástegui R
    Rev Invest Clin; 2005; 57(4):522-31. PubMed ID: 16315636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Results of statistical analysis with a computer of the median effective dose and plasma levels of drugs in the treatment of epilepsy].
    Oller L; Lagunas Hernandez MA; Russi Tintore A; Sabater Tobella J; Oller Daurella L
    Arch Neurobiol (Madr); 1977; 40(1):37-46. PubMed ID: 856097
    [No Abstract]   [Full Text] [Related]  

  • 6. Improved tolerability and efficacy in epilepsy patients with extended-release carbamazepine.
    Ficker DM; Privitera M; Krauss G; Kanner A; Moore JL; Glauser T
    Neurology; 2005 Aug; 65(4):593-5. PubMed ID: 16116122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preliminary observations of serum carbamazepine concentration in epileptic patients.
    Cereghino JJ; Meter JC; Brock JT; Penry JK; Smith LD; White BG
    Neurology; 1973 Apr; 23(4):357-66. PubMed ID: 4736124
    [No Abstract]   [Full Text] [Related]  

  • 8. Carbamazepine drug interactions: the influence of concurrent drug therapy on serum concentrations of carbamazepine and its epoxide metabolite.
    Wang RB; Liu LT; Yiu CH; Chang TY
    Zhonghua Yi Xue Za Zhi (Taipei); 1990 Apr; 45(4):222-32. PubMed ID: 2168269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic serum levels for new antiepileptic drugs.
    Haruda FD
    Arch Neurol; 1999 Oct; 56(10):1300. PubMed ID: 10520950
    [No Abstract]   [Full Text] [Related]  

  • 10. Efficacy of carbamazepine and valproate as monotherapy for early epilepsy and single seizures.
    Marson AG; Williamson PR; Taylor S; Maguire M; Chadwick DW
    Neurology; 2006 Nov; 67(10):1872-5. PubMed ID: 17130429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The optimization of epilepsy therapy with finlepsin].
    Gromov SA; Khorshev SK; Mikhaĭlov VA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2000; 100(9):32-5. PubMed ID: 11026133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Possible hazard of valpromide-carbamazepine combination therapy in epilepsy.
    Meijer JW; Binnie CD; Debets RM; van Parys JA; de Beer-Pawlikowski NK
    Lancet; 1984 Apr; 1(8380):802. PubMed ID: 6143129
    [No Abstract]   [Full Text] [Related]  

  • 13. Evaluation of therapeutic drug level monitoring of phenobarbital, phenytoin and carbamazepine in Iranian epileptic patients.
    Babaei A; Eslamai MH
    Int J Clin Pharmacol Ther; 2007 Feb; 45(2):121-5. PubMed ID: 17323792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carbamazepine as an anticonvulsant: a pilot study.
    Troupin AS; Green JR; Levy RH
    Neurology; 1974 Sep; 24(9):863-9. PubMed ID: 4277388
    [No Abstract]   [Full Text] [Related]  

  • 15. Severe carbamazepine toxicity induced by concurrent erythromycin therapy.
    Mota CR; Carvalho C; Mota C; Ferreira P; Vilarinho A; Pereira E
    Eur J Pediatr; 1996 Apr; 155(4):345. PubMed ID: 8777933
    [No Abstract]   [Full Text] [Related]  

  • 16. [Role of the pharmacokinetic parameters of carbamazepine in optimizing epilepsy treatment].
    Okudzhava VM; Antadze ZI; Chankvetadze BG; Vetrogon FG
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1987; 87(9):1327-9. PubMed ID: 3425074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of felbamate on phenytoin and carbamazepine serum concentrations.
    Graves NM; Holmes GB; Fuerst RH; Leppik IE
    Epilepsia; 1989; 30(2):225-9. PubMed ID: 2647472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carbamazepine-induced necrotizing leukocytoclastic vasculitis with a 20-year latency.
    Pranteda G; D 'arino A; Pigliacelli F; Pranteda G; Rampioni-Vinciguerra GL; Bottoni U
    G Ital Dermatol Venereol; 2018 Apr; 153(2):285-286. PubMed ID: 29564877
    [No Abstract]   [Full Text] [Related]  

  • 19. The epoxide of carbamazepine.
    McKauge L; Tyrer JH; Eadie MJ
    Clin Exp Neurol; 1979; 16():95-104. PubMed ID: 550961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between serum mono-hydroxy-carbazepine concentrations and adverse effects in patients with epilepsy on high-dose oxcarbazepine therapy.
    Striano S; Striano P; Di Nocera P; Italiano D; Fasiello C; Ruosi P; Bilo L; Pisani F
    Epilepsy Res; 2006 May; 69(2):170-6. PubMed ID: 16515857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.